Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE\NAPROXEN Cause Swelling? 34 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Swelling have been filed in association with ESOMEPRAZOLE\NAPROXEN. This represents 0.6% of all adverse event reports for ESOMEPRAZOLE\NAPROXEN.

34
Reports of Swelling with ESOMEPRAZOLE\NAPROXEN
0.6%
of all ESOMEPRAZOLE\NAPROXEN reports
12
Deaths
18
Hospitalizations

How Dangerous Is Swelling From ESOMEPRAZOLE\NAPROXEN?

Of the 34 reports, 12 (35.3%) resulted in death, 18 (52.9%) required hospitalization, and 13 (38.2%) were considered life-threatening.

Is Swelling Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE\NAPROXEN. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE\NAPROXEN Cause?

Chronic kidney disease (2,714) Renal failure (2,374) Acute kidney injury (1,120) Death (705) Drug ineffective (459) Off label use (440) Nausea (431) End stage renal disease (349) Tubulointerstitial nephritis (315) Hyperhidrosis (308)

What Other Drugs Cause Swelling?

ADALIMUMAB (10,906) METHOTREXATE (10,702) ETANERCEPT (10,467) TOCILIZUMAB (9,420) ABATACEPT (9,226) LEFLUNOMIDE (8,885) RITUXIMAB (8,477) PREDNISONE (7,968) HYDROXYCHLOROQUINE (7,937) CERTOLIZUMAB PEGOL (7,748)

Which ESOMEPRAZOLE\NAPROXEN Alternatives Have Lower Swelling Risk?

ESOMEPRAZOLE\NAPROXEN vs ESTAZOLAM ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL CYPIONATE ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\LEVONORGESTREL ESOMEPRAZOLE\NAPROXEN vs ESTRADIOL\NORETHINDRONE

Related Pages

ESOMEPRAZOLE\NAPROXEN Full Profile All Swelling Reports All Drugs Causing Swelling ESOMEPRAZOLE\NAPROXEN Demographics